{"id":20213,"date":"2023-03-13T13:06:38","date_gmt":"2023-03-13T05:06:38","guid":{"rendered":"https:\/\/tbenews.com\/tbe\/?p=20213"},"modified":"2023-03-15T09:32:21","modified_gmt":"2023-03-15T01:32:21","slug":"snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria","status":"publish","type":"post","link":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/","title":{"rendered":"Snapshot week 11\/2023 <br>Immunization status in patients with multiple sclerosis, Austria"},"content":{"rendered":"<span class=\"cb-itemprop\" itemprop=\"reviewBody\">\n<p class=\"wp-block-paragraph\">Berek et al.<br>Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in Austria<br><em>Eur J Neurol.<\/em> 2023;10.1111\/ene.15748. doi: 10.1111\/ene.15748<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Administration of attenuated vaccines is contraindicated in MS patients receiving immunosuppressive agents. It is recommended to complete vaccinations 4\u20136 weeks before initiating disease-modifying therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Representative data about the overall immunization status was lacking in the MS population. Therefore, a cross-sectional, monocenter study to examine the vaccination status against 17 different pathogens was carried out in a cohort of MS patients (424 in total, mean age 43\u00b112 years, range 20\u201379 years) in Austria in 2020\/2021. Patients were considered to have sufficient vaccination when fulfilling the recommendations of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most MS patients were immunized against tetanus, diphtheria and poliomyelitis (90%), only a very low proportion was vaccinated to protect against pneumococcal disease (6%) and meningococcal disease (4%).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">70% of the MS patients had received TBE vaccines, and this matched with the rate of serological examinations (IgG antibodies measured by ELISA). However, only 17% had timely vaccinations\/boosters.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Overall, higher vaccination rates were associated with younger age and education level. Misinformation on infectious diseases and vaccines were associated with lower vaccination rates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The majority of MS patients did not fulfill vaccination recommendations (including TBE) and efforts to increase vaccination rates should be promoted.<\/p>\n<\/span>","protected":false},"excerpt":{"rendered":"<p>Berek et al.Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaEur J Neurol. 2023;10.1111\/ene.15748. doi: 10.1111\/ene.15748 Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Administration of attenuated vaccines is contraindicated in MS patients receiving immunosuppressive agents. It is recommended to complete vaccinations 4\u20136 weeks before initiating disease-modifying therapies. Representative data about the overall immunization status was lacking in the MS population. Therefore, a cross-sectional, monocenter study to examine the vaccination status against 17 different pathogens was carried out in a cohort of MS patients (424 in total, mean age 43\u00b112 years, range 20\u201379 years) in Austria in 2020\/2021. Patients were considered to have sufficient vaccination when fulfilling the recommendations of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection. Most MS patients were immunized against tetanus, diphtheria and poliomyelitis (90%), only a very low proportion was vaccinated to protect against pneumococcal disease (6%) and meningococcal disease (4%). 70% of the MS patients had received TBE vaccines, and this matched with the rate of serological examinations (IgG antibodies measured by ELISA). However, only 17% had timely vaccinations\/boosters. Overall, higher vaccination rates were associated with younger age and education level. Misinformation on infectious diseases and vaccines were associated with lower vaccination rates. The majority of MS patients did not fulfill vaccination recommendations (including TBE) and efforts to increase vaccination rates should be promoted.<\/p>\n","protected":false},"author":1354,"featured_media":12864,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[18],"tags":[292,983,844],"coauthors":[581],"class_list":["post-20213","post","type-post","status-publish","format-standard","has-post-thumbnail","category-snapshot","tag-austria","tag-multiple-sclerosis","tag-vaccination-rate"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book\" \/>\n<meta property=\"og:description\" content=\"Berek et al.Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaEur J Neurol. 2023;10.1111\/ene.15748. doi: 10.1111\/ene.15748 Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Administration of attenuated vaccines is contraindicated in MS patients receiving immunosuppressive agents. It is recommended to complete vaccinations 4\u20136 weeks before initiating disease-modifying therapies. Representative data about the overall immunization status was lacking in the MS population. Therefore, a cross-sectional, monocenter study to examine the vaccination status against 17 different pathogens was carried out in a cohort of MS patients (424 in total, mean age 43\u00b112 years, range 20\u201379 years) in Austria in 2020\/2021. Patients were considered to have sufficient vaccination when fulfilling the recommendations of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection. Most MS patients were immunized against tetanus, diphtheria and poliomyelitis (90%), only a very low proportion was vaccinated to protect against pneumococcal disease (6%) and meningococcal disease (4%). 70% of the MS patients had received TBE vaccines, and this matched with the rate of serological examinations (IgG antibodies measured by ELISA). However, only 17% had timely vaccinations\/boosters. Overall, higher vaccination rates were associated with younger age and education level. Misinformation on infectious diseases and vaccines were associated with lower vaccination rates. The majority of MS patients did not fulfill vaccination recommendations (including TBE) and efforts to increase vaccination rates should be promoted.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/\" \/>\n<meta property=\"og:site_name\" content=\"TBE Book\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-13T05:06:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-15T01:32:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Shaqeez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaqeez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/\"},\"author\":{\"name\":\"Shaqeez\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\"},\"headline\":\"Snapshot week 11\\\/2023 Immunization status in patients with multiple sclerosis, Austria\",\"datePublished\":\"2023-03-13T05:06:38+00:00\",\"dateModified\":\"2023-03-15T01:32:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/\"},\"wordCount\":236,\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"keywords\":[\"Austria\",\"Multiple sclerosis\",\"vaccination rate\"],\"articleSection\":[\"Snapshot\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/\",\"name\":\"Snapshot week 11\\\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"datePublished\":\"2023-03-13T05:06:38+00:00\",\"dateModified\":\"2023-03-15T01:32:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2017\\\/11\\\/TBE-Snapshots.jpg\",\"width\":1180,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Snapshot week 11\\\/2023 Immunization status in patients with multiple sclerosis, Austria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#website\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"name\":\"The TBE Book\",\"description\":\"Tick-borne Encephalitis (TBE)\",\"publisher\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#organization\",\"name\":\"Global Health Press\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"contentUrl\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/wp-content\\\/uploads\\\/2019\\\/01\\\/logo-PNG.png\",\"width\":1000,\"height\":715,\"caption\":\"Global Health Press\"},\"image\":{\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/#\\\/schema\\\/person\\\/2bc2ab1f56f93257537a0ce8de903224\",\"name\":\"Shaqeez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g\",\"caption\":\"Shaqeez\"},\"url\":\"https:\\\/\\\/tbenews.com\\\/tbe\\\/author\\\/shaqeez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/","og_locale":"en_US","og_type":"article","og_title":"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book","og_description":"Berek et al.Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in AustriaEur J Neurol. 2023;10.1111\/ene.15748. doi: 10.1111\/ene.15748 Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Administration of attenuated vaccines is contraindicated in MS patients receiving immunosuppressive agents. It is recommended to complete vaccinations 4\u20136 weeks before initiating disease-modifying therapies. Representative data about the overall immunization status was lacking in the MS population. Therefore, a cross-sectional, monocenter study to examine the vaccination status against 17 different pathogens was carried out in a cohort of MS patients (424 in total, mean age 43\u00b112 years, range 20\u201379 years) in Austria in 2020\/2021. Patients were considered to have sufficient vaccination when fulfilling the recommendations of the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection. Most MS patients were immunized against tetanus, diphtheria and poliomyelitis (90%), only a very low proportion was vaccinated to protect against pneumococcal disease (6%) and meningococcal disease (4%). 70% of the MS patients had received TBE vaccines, and this matched with the rate of serological examinations (IgG antibodies measured by ELISA). However, only 17% had timely vaccinations\/boosters. Overall, higher vaccination rates were associated with younger age and education level. Misinformation on infectious diseases and vaccines were associated with lower vaccination rates. The majority of MS patients did not fulfill vaccination recommendations (including TBE) and efforts to increase vaccination rates should be promoted.","og_url":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/","og_site_name":"TBE Book","article_published_time":"2023-03-13T05:06:38+00:00","article_modified_time":"2023-03-15T01:32:21+00:00","og_image":[{"width":1180,"height":250,"url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","type":"image\/jpeg"}],"author":"Shaqeez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Shaqeez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#article","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/"},"author":{"name":"Shaqeez","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224"},"headline":"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria","datePublished":"2023-03-13T05:06:38+00:00","dateModified":"2023-03-15T01:32:21+00:00","mainEntityOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/"},"wordCount":236,"publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","keywords":["Austria","Multiple sclerosis","vaccination rate"],"articleSection":["Snapshot"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/","url":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/","name":"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria - TBE Book","isPartOf":{"@id":"https:\/\/tbenews.com\/tbe\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#primaryimage"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#primaryimage"},"thumbnailUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","datePublished":"2023-03-13T05:06:38+00:00","dateModified":"2023-03-15T01:32:21+00:00","breadcrumb":{"@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#primaryimage","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2017\/11\/TBE-Snapshots.jpg","width":1180,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/tbenews.com\/tbe\/snapshot-week-11-2023-immunization-status-in-patients-with-multiple-sclerosis-austria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tbenews.com\/tbe\/"},{"@type":"ListItem","position":2,"name":"Snapshot week 11\/2023 Immunization status in patients with multiple sclerosis, Austria"}]},{"@type":"WebSite","@id":"https:\/\/tbenews.com\/tbe\/#website","url":"https:\/\/tbenews.com\/tbe\/","name":"The TBE Book","description":"Tick-borne Encephalitis (TBE)","publisher":{"@id":"https:\/\/tbenews.com\/tbe\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tbenews.com\/tbe\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tbenews.com\/tbe\/#organization","name":"Global Health Press","url":"https:\/\/tbenews.com\/tbe\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/","url":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","contentUrl":"https:\/\/tbenews.com\/tbe\/wp-content\/uploads\/2019\/01\/logo-PNG.png","width":1000,"height":715,"caption":"Global Health Press"},"image":{"@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tbenews.com\/tbe\/#\/schema\/person\/2bc2ab1f56f93257537a0ce8de903224","name":"Shaqeez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g2ce4daa834e38f5ff18a9faa82d1596d","url":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1c6a04352cef6bb74d75fceabfabb30473aa9958d64ddd93f1feaec90954df3?s=96&d=mm&r=g","caption":"Shaqeez"},"url":"https:\/\/tbenews.com\/tbe\/author\/shaqeez\/"}]}},"_links":{"self":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/users\/1354"}],"replies":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/comments?post=20213"}],"version-history":[{"count":2,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20213\/revisions"}],"predecessor-version":[{"id":20215,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/posts\/20213\/revisions\/20215"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media\/12864"}],"wp:attachment":[{"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/media?parent=20213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/categories?post=20213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/tags?post=20213"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/tbenews.com\/tbe\/wp-json\/wp\/v2\/coauthors?post=20213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}